LRRC32 and cancer: Platelet-derived TGF-β is complexed with glycoprotein A repetitions predominant (GARP) protein to induce both NK cells and T cells anergy [79], while thrombin involved in platelet-bound GARP cleavage and the liberation of active TGF-β supports cancer immune evasion [80].